Atripla and Ondansetron drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate) and Ondansetron (ondansetron). Common drug interactions include quality of life decreased among females and emotional distress among males.
The phase IV clinical study analyzes what interactions people have when they take Atripla and Ondansetron. It is created by eHealthMe based on reports of 359 people who take the same drugs from the FDA, and is updated regularly.
What is Atripla?
Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.
What is Ondansetron?
Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,739 Ondansetron users. Check the latest studies of Ondansetron.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
359 people who take Atripla and Ondansetron together, and have interactions are studied.
What are the common drug interactions of Atripla and Ondansetron, by gender? *
What are the common drug interactions of Atripla and Ondansetron, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Atripla and Ondansetron?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Atripla (36,036 reports)
- Ondansetron (122,739 reports)
Browse all drug interactions of Atripla and Ondansetron:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Atripla:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ondansetron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atripla and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ondansetron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate and ondansetron (the active ingredients of Atripla and Ondansetron, respectively), and Atripla and Ondansetron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Olmesartan Medoxomil vs. Hctz, side effect and effectiveness comparison - a second ago
- Could Inderal cause Blood Count Abnormal? - 3 seconds ago
- Could Anafranil cause Erection Problems? - 4 seconds ago
- Could Cardizem cause Neck Mass? - 5 seconds ago
- Could Carfilzomib cause Pain? - 8 seconds ago
- Could Zinbryta cause Stress And Anxiety? - 9 seconds ago
- Could Zide cause Neutrophilia? - 9 seconds ago
- Could Indapamide cause Osteonecrosis Of Jaw? - 16 seconds ago
- Could Indapamide cause Injection Site Nodule? - 17 seconds ago
- Could Pazeo cause Lacrimation Increased? - 20 seconds ago